Experienced Representation for Ovarian Cancer Survivors & Families

Our firm is representing women who have been diagnosed with ovarian cancer that may have been caused by perineal exposure to talcum powder products. Successive juries have returned verdicts against Johnson & Johnson for failing to warn its customers of a potential cancer risk related to its Baby Powder and Shower-to-Shower products. We are helping ovarian cancer survivors—and family members of those who have passed away—determine whether they may have a potential claim related to their illness.

There are several criteria important to considering whether a diagnosis of ovarian cancer may be linked to talcum powder products. These include:

  • The length and consistency of use of talcum powder products;
  • Family history of ovarian or breast cancer; and
  • History of birth control use.

We have a comprehensive review process in which we analyze all of the facts pertaining to your illness, access your medical records, and even microscopically analyze tissue samples from previous surgeries. While we cannot promise results to anyone, it is our goal to assure each client that she will know much more about her cancer after working with us.

The talc/ovarian cancer line of litigation is very new. The first case of this kind was tried before a jury in the Fall of 2013. But scientists have long suspected a link between perineal use of talc-based products and the development of ovarian cancer. In the mid-1980s, Harvard researchers conducted a study of 235 women between 18-76 years of age diagnosed with ovarian cancer. 114 (48.5%) of the women were found to have been exposed to talcum powder in their perineal region. This was a rate of exposure significantly higher than that of the non-cancer control group (39.3%). The study observed that exposure to talc did not appear to be the primary cause of ovarian cancer, but that “the proportion of ovarian cancer incidence attributable to this level of talc exposure is about 10%.” “Nevertheless,” Harvard emphasized, “given the poor prognosis for ovarian cancer, any potentially harmful exposures should be avoided, particularly those with limited benefits. For this reason, we discourage the use of talc in genital hygiene, particularly as a daily habit.”

Johnson & Johnson continues to dispute the allegations that its Baby Power and Shower-to-Shower products (which are composed primarily of talcum powder) can lead to the development of ovarian cancer. However, of the three cases which have gone to trial thus far, all juries have found Johnson & Johnson liable for failing to disclose this research to its customers. Two of the three cases have resulted in substantial damages awards against the company: first, an award of $72 million to the family of an ovarian cancer victim; and second, a verdict of $55 million on behalf of a woman who contracted ovarian cancer but was later cured. But juries awarded substantial sums of punitive damages against Johnson & Johnson.

Contact an Experienced Columbia Personal Injury Lawyer at Chappell Smith & Arden, P.A.

If you or a loved one would like more information about the link between ovarian cancer and talc-based products, contact a Columbia personal injury lawyer at Chappell Smith & Arden, P.A. for experienced help moving forward. Since 1993, our lawyers have been committed to protecting our clients’ rights and interests’ and helping them obtain – and keep – the benefits to which they are entitled.

Call our firm at 866-881-8623 or contact us online to set up a free, no obligations initial consult with one of our lawyers. During this meeting, you can find out more about your rights, as well as how we can help you.

From our six office locations throughout South Carolina, our attorneys provide the highest quality legal services to injured people and families in Columbia, Alken, Camden, Sumter, Orangeburg, Greenville, Florence, Beaufort, Irmo, Spartanburg, Myrtle Beach, Hilton Head Island, West Columbia, Rock Hill, Charleston, Lexington, Winnsboro, Summerville, and throughout South Carolina.